Fact CheckerSign in

NCT02107989Recruiting

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

Source: ClinicalTrials.gov · Last updated 19 Oct 2026

Brief summary (registry, in English)

Objectives: The overall study objective is to compare the sensitivities and specificities of morphometric analysis techniques using structural MRI images based on pre- and postsurgical localization of epileptic foci in patients undergoing presurgical evaluation for medically refractory epilepsy. To carry out these analyses, we aim to establish an age-stratified normative imaging database using healthy volunteers. Additional objectives are to identify abnormal networks in these patients using resting state fMRI/EEG and MEG/EEG, and to use language and memory fMRI tasks to examine the effects of epileptogenic zones and surgery on cognitive function and the networks associated with these functions. Study population: 300 adults and children (age 8 and older) with uncontrolled focal epilepsy, and 200 age-stratified healthy volunteers. Design: A retrospective and prospective natural history study. Research procedures for patients in this study include neuropsychological testing and 1-4 MRI sessions during presurgical evaluation and an additional 1-3 MRI sessions and neuropsychological testing approximately 12 months post-operatively. Research testing (such as research neuropsychological tests or MRI scanning sequences) will be done during a visit for clinical testing whenever possible, likely reducing the number of required visits. Patients will also have optional MEG and 7T structural imaging. Data will also be obtained from patients who have already undergone epilepsy surgery if they had procedures as outlined in the protocol and are willing to share the data. Healthy volunteers will receive a subset of the pre-operative procedures for patients, requiring at least 3 visits. In order to ensure adequate data acquisition, subjects may be re-scanned up to three times for the portions of the study in which they participated, possibly requiring additional visits. Outcome measures: The main outcomes will be establishment of normative values for morphometric analysis methods in age-stratified normal controls, and comparison of the sensitivity and specificity of these measures to pre- and postsurgical localization of the epileptogenic zone. Secondary outcome measures will include determination of the sensitivity and specificity of source localization using MEG/EEG and resting state fMRI/EEG, and to evaluate changes in activation during rest, as well as language and memory fMRI tasks in patients pre- and postsurgically, to examine the effects of epileptogenic zones and surgery on cognitive function and the networks underlying these functions.

Status (registry)
Recruiting
Study type
Observational
Enrollment
700 (estimated)
First submitted
5 Apr 2014
Start date
11 Mar 2014
Primary completion date
30 Mar 2028
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Diseases
Epilepsy
NCT number
NCT02107989

What you commit to

  • Study type: Observational
  • Planned participants: 700
  • From 11 Mar 2014 to the primary completion date, 30 Mar 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Contraindications to MRI or MEG studies (such as pacemakers, cochlear implants, shrapnel, permanent eyeliner)
  • Pregnancy. All females of childbearing potential must have a negative pregnancy test prior to MRI scanning
  • Contraindications to MRI or MEG studies (such as pacemakers, cochlear implants, shrapnel, permanent eyeliner)
  • Pregnancy. All females of childbearing potential must have a negative pregnancy test prior to MRI scanning

Other illness

  • Claustrophobia or anxiety disorders exacerbated by the MRI scanner
  • Claustrophobia or anxiety disorders exacerbated by the MRI scanner
  • Significant medical conditions that may affect the central nervous system, such as psychiatric disorders (such as mood disorders, psychotic disorders, substance abuse or dependence), significant neurologic disorders (such as brain injury, neurodegenerative disorders, multiple sclerosis, stroke, movement disorders, epilepsy), or active systemic disease that may affect the central nervous system (such as uncontrolled hypertension, autoimmune disorders or other inflammatory disorders, neoplastic disease)
  • Use of centrally acting medications in the past 6 weeks, such as benzodiazepines, barbiturates, antidepressants, beta-blockers, and drugs for treating epilepsy or migraine

Other

  • -Not able or willing to give consent or do not have an appropriate surrogate who can provide consent

Who the study is looking for

  • Had epilepsy surgery with presurgical evaluation under 18-N-0066
  • Age 8 and up at the time of epilepsy surgery evaluation
  • Had a preoperative structural brain MRI of the type used in this protocol
  • Age 8 and older
  • Ability to give informed consent or have a parent/guardian able to provide informed consent if a child.
  • Ability to cooperate with MRI scanning without anesthesia

Criteria the registry did not label

  • INCLUSION CRITERIA FOR PATIENTS:
  • Age 8 and older
  • Evaluated or under evaluation for epilepsy surgery under protocol 18-N-0066,11-N-0051 or 16-N-0041
  • Documentation of focal epilepsy based on MRI, EEG and/or ictal semiology
  • Ability to give informed consent, have or be able to assign a legally authorized representative able to give consent (for adults without consent capacity), or parent/guardian able to provide informed consent (for a child).

Age in the registry: 8 years to 120 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Institutes of Health Clinical Center
Coordinator of this site? Confirm its status
BethesdaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.